NCT00439686View on ClinicalTrials.gov

Study of ZIO-201 in Advanced Sarcoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2013

Conditions
Advanced Sarcoma
Interventions
DRUG

ZIO-201

ZIO-201 given for 3 consecutive days to be repeated every 21 days for up to 6 months

Trial Locations (2)

Unknown

Santa Monica

Ann Arbor

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY